Author: Fabien Pamelard

Fluidigm announces collaboration agreement with Imaging CRO ImaBiotech to increase biopharma access to Imaging Mass Cytometry
Following toxicity and efficacy markers in skin substructures using Mass Spectrometry Imaging (MSI)
Metabolomics and Metabolite Profiling using Mass Spectrometry Imaging (MSI): A New Biochemical Tool for Drug Discovery
Quantitative Mass Spectrometry Imaging (QMSI) of endogenous insulin in mouse pancreas using modified Insulin

Search news